Biomerica (BMRA) FCF Margin (2010 - 2026)

Biomerica has disclosed FCF Margin across 17 years of filings, most recently posting 126.65% for Q1 2026.

• FCF Margin for Q1 2026 came in at 126.65%, down 3326.0% year-over-year; the trailing twelve-month figure through Feb 2026 was 73.28% (up 154.0% YoY), and the FY2025 annual result was 72.32%, up 2762.0% from the prior year.
• FCF Margin came in at 126.65% for Q1 2026 at Biomerica, down from 81.9% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 30.6% in Q1 2022 to a low of 177.09% in Q1 2024.
• The 5-year median for FCF Margin is 86.91% (2023), against an average of 84.28%.
• Across the five-year window, FCF Margin plunged 18640 bps in 2023 and soared 8370 bps in 2025, its largest moves.
• Biomerica's FCF Margin stood at 83.47% in 2022, then jumped by 35 bps to 54.12% in 2023, then climbed by 11 bps to 48.35% in 2024, then tumbled by 69 bps to 81.9% in 2025, then tumbled by 55 bps to 126.65% in 2026.
• The last three FCF Margin figures came in at 126.65% (Q1 2026), 81.9% (Q4 2025), and 19.42% (Q3 2025), per Business Quant data.